Jordan Cloyd,The James Cancer Center
- Surgical Oncology
I am a surgical oncologist who cares for patients with gastrointestinal, hepatopancreatobiliary, neuroendocrine, and peritoneal surface malignancies. I believe in a collaborative approach to patient care. Every patient deserves a multidisciplinary evaluation to consider the best individualized treatment plan for them. I strive to ensure patients are fully informed so that we can partner together to make shared treatment decisions.
Many of my patients present with advanced or metastatic disease and I use innovative approaches such as neoadjuvant therapy or intraperitoneal chemotherapy (also known as HIPEC) to achieve the best outcomes. When possible, I prioritize minimally invasive approaches in order to minimize postoperative pain and recovery time.
I consider research to be an important part of my work and I’ve been published in journals such as Cancer, JAMA Surgery, and the Journal of Clinical Oncology. Through studying patient outcomes and introducing clinical trials, I hope to help both my current patients as well as future ones. I also enjoy teaching and I currently serve as an assistant professor in Surgery at The Ohio State University.
I enjoy working with a highly experienced and specialized team of providers here at The James who are passionate about caring for patients with cancer. I am proud to work at one of the leading cancer centers in the country knowing that patients are receiving the best care possible.
Education and Background
University of California School of Medicine
San Francisco, CA
Stanford Hospital and Clinics
Palo Alto, CA
MD Anderson Cancer Center
- American Board of Surgery
- Department of Surgery
- Division of Surgical Oncology
I see patients at
The James at Martha Morehouse Medical Plaza
2050 Kenny Road, Columbus, Ohio 43221
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Cloyd has reported no financial relationships with medical device, research and/or drug companies.